# Rheumatoid Arthritis: Developing Drug Products for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/rheumatoid-arthritis-developing-drug-products-for-treatment/f6725d58-9ccd-41cf-8684-52aca25cd029

> FDA guidance document: Rheumatoid Arthritis: Developing Drug Products for Treatment. Issue date: May 31, 2013. Get complete insights and analysis.

---

## Details

- Title: Rheumatoid Arthritis: Developing Drug Products for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2013-05-31
- Last Changed: 2020-04-23
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-0571">FDA-2013-D-0571</a>

## Related Documents

- [Acute Myeloid Leukemia:  Developing Drugs and Biological Products for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/acute-myeloid-leukemia-developing-drugs-and-biological-products-for-treatment-draft-guidance-for-industry/8143a606-18fc-488c-b3ab-4c23bdcd999a)
- [Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/pregnant-women-scientific-and-ethical-considerations-for-inclusion-in-clinical-trials/674ff9d8-e752-4113-b7fd-bc85b7646bd3)
- [Investigational New Drug Applications Prepared and Submitted by Sponsor-Investigators](https://www.globalkeysolutions.net/guidances/guidance-document/investigational-new-drug-applications-prepared-and-submitted-by-sponsor-investigators/9c10b828-60b1-4f2f-acda-7011cf2ad95d)